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Following infection, Human Immunodeficiency Virus
type 1 (HIV-1) becomes stably integrated into the genome
of the host cell. It depends, therefore, on host cell factors
to regulate its transcriptional output, both positively and
negatively. HIV-1 transcriptional silencing requires chro-
matin remodelling and transcriptional repressor com-
plexes, as well as heterochromatin formation at the
integrated provirus. An important feature of silenced pro-
viruses is their ability to be re-activated by either the viral
transcription factor, Tat, or environmental stimuli. Activa-
tion of transcription is also controlled by numerous host
cell factors. We have identified novel mechanisms of tran-
scriptional activation and repression that depend on cel-
lular macromolecular complexes such as proteasome and
nuclear exosome. I will discuss recent developments in
understanding the mechanisms by which these complexes
control HIV-1 transcription, and the implications for viral
latency.
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